Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.



Gadolinium-based nanoscale MRI contrast agents for tumor imaging

Author affiliations

Abstract

Gadolinium-based nanoscale magnetic resonance imaging (MRI) contrast agents (CAs) have gained significant momentum as a promising nanoplatform for detecting tumor tissue in medical diagnosis, due to their favorable capability of enhancing the longitudinal relaxivity (r1) of individual gadolinium ions, delivering to the region of interest a large number of gadolinium ions, and incorporating different functionalities. This mini-review highlights the latest developments and applications, and simultaneously gives some perspectives for their future development.

Graphical abstract: Gadolinium-based nanoscale MRI contrast agents for tumor imaging

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 08 Feb 2017, accepted on 28 Mar 2017 and first published on 28 Mar 2017


Article type: Review Article
DOI: 10.1039/C7TB00382J
Citation: J. Mater. Chem. B, 2017, Advance Article
  •   Request permissions

    Gadolinium-based nanoscale MRI contrast agents for tumor imaging

    Y. Cao, L. Xu, Y. Kuang, D. Xiong and R. Pei, J. Mater. Chem. B, 2017, Advance Article , DOI: 10.1039/C7TB00382J

Search articles by author